FDA Single-Use Device Reuse Policy Could Be More Stringent By Spring
This article was originally published in The Gray Sheet
Executive SummaryFDA's policy exempting single-use device reprocessors from requiring 510(k) clearance may undergo a significant reconsideration in the Center for Devices and Radiological Health by next spring, Office of Compliance Special Assistant to the Director Caspar Uldricks told attendees of the Food & Drug Law Institute's 42nd Annual Education Conference Dec. 17 in Washington, D.C.
You may also be interested in...
Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.
With the pre-GDUFA backlog largely acted upon, the FDA expects ANDA approvals to decrease, but supplement actions to increase in FY 2020 and FY 2021.
February and March inspections deferred unless any are deemed mission critical. China director remains behind as staff evacuate.